Taytulla

Allergan, Inc.🇺🇸 United States

FDA Page

Effective Date: Oct 25, 2024
Approval ID: 2fa8e8dc-f7b0-429a-b554-0e3c4291c92c
Products: 0 registered
Version: 16

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TAYTULLA safely and effectively. See full prescribing information for TAYTULLA. TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), for oral use Initial U.S. Approval: 1968

Quick Stats

Total Products0

Labelers1

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.